{"name":"Alkem Laboratories","slug":"alkem","ticker":"ALKEM.NS","exchange":"NSE","domain":"alkemlabs.com","description":"Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets.","hq":"Mumbai, India","founded":1973,"employees":"18785","ceo":"Sandeep Singh","sector":"Anti-Infectives / GI Generics","stockPrice":5576.5,"stockChange":114,"stockChangePercent":2.09,"marketCap":"$7.0B","metrics":{"revenue":1488377298.6866403,"revenueGrowth":10.7,"grossMargin":62.9,"rdSpend":0,"netIncome":247619057.088,"cash":538015908.2930259,"dividendYield":0.93,"peRatio":28.1,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Ceftriaxone patent cliff ($100.0M at risk)","drug":"Ceftriaxone","type":"patent_expiry","sentiment":"negative"},{"date":"2025-06-01","label":"Metformin patent cliff ($50.0M at risk)","drug":"Metformin","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-14","type":"earnings","headline":"Alkem Laboratories reports 15% rise in Q3 FY24 net profit","summary":"Alkem Laboratories reported a 15% increase in net profit for the third quarter of FY24, driven by strong sales growth in the domestic market.","drugName":"","sentiment":"positive"},{"date":"2023-08-25","type":"deal","headline":"Alkem Laboratories partners with US-based firm for API manufacturing","summary":"Alkem Laboratories has partnered with a US-based firm to manufacture active pharmaceutical ingredients (APIs) for its products.","drugName":"","sentiment":"neutral"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPU1IxM1dUdFM3Q0I5b0xyMThhSElCVW5DY2ZWX2FlM0xRZ2VZdndsTUFUbDRUUzJnMW5aRE5TTEM1RFJjcTNMNWo3RjZzcWctaUM3dEVEN2piNG5BazY1VVFPdkp3aWd5ODRmUGhMNlJqV1NfWENvNFRMbm1vaGxjNWlDVWxSN0tZNzBr?oc=5","date":"2026-02-13","type":"deal","source":"Yahoo Finance Singapore","summary":"India's Alkem Labs unit to buy up to 55% of Occlutech for $118 million - Yahoo Finance Singapore","headline":"India's Alkem Labs unit to buy up to 55% of Occlutech for $118 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPSzJmQ3dWV016SklXVHA3VWV0MllQVFNPbWwxUy1Ca2hQaFN6eU53OUhHNy1xdzI1THQwelFUalJKc3J1VndZZ29GYXBTRGZpVmtsc3NuUG9kZHNnSktlRDQzQ0hkdzRKU184Vmw1cTF6X3dDOWpnbUZHaWwwT2RZd2c5WFlub3Y4UmRpTmNqVlYxdGN6ZnJkaWN1MVhtMDh6Ym1TU3VXRGthalZIWFZWOXpHWC1qdkhKSk80eG8zWmFZbHNKNUNTdDlTZ3RDUQ?oc=5","date":"2026-01-23","type":"regulatory","source":"Reuters","summary":"Indian drugmakers get regulatory nod to sell generic Wegovy, heating obesity‑drug race - Reuters","headline":"Indian drugmakers get regulatory nod to sell generic Wegovy, heating obesity‑drug race","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNR2V1Q0tsZ1BIWHFZX3phMjZMNGhVeUJaaWREdC0xcHd4VWhjTVFnUl9qVTY2dk1Ia2NZMmx1MVJTZGlFMW9MNGstQWR3TmdfUnVzM2ZaTWhPR1M5MVlza1l6SU90ejJZX3Znc29rRU5BVUdBQ0dDdGtUOXVFaUlBN3FhN2Q3SmQz?oc=5","date":"2025-08-12","type":"pipeline","source":"Yahoo Finance","summary":"United States Epilepsy Drugs Market Trends and Company Analysis Report 2025-2033 Featuring Eisai, UCB, H. Lundbeck, GW Pharmaceuticals, Abbott, Alkem Laboratories, Bausch Health, GSK - Yahoo Finance","headline":"United States Epilepsy Drugs Market Trends and Company Analysis Report 2025-2033 Featuring Eisai, UCB, H. Lundbeck, GW P","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNdGd1dloxclM2TUVNdHA0b3FreHBvM04zb3o5MDAtREZpWTBqMjFXYkdHQUlMUVNVOFQtRWRtdjh6M2dpS1JjaTVQLVFOUGE1TWk4WkNPYW9XaXRiRVg5eHJFcDNDQXRzVnFhbk01WWpQLU9kU0pia1czTkJHYzM0Ui12TUMwVlNaaUdWNWRabFE1cVlIYzk1X3g3MFdqZk9BekxBUDFQbUczSWVLaFVJMHQ4WWlDRHBULV8xUGhlMkpjVTdveWFHQg?oc=5","date":"2024-09-27","type":"pipeline","source":"Reuters","summary":"India's Alkem Labs denies its products failed quality test - Reuters","headline":"India's Alkem Labs denies its products failed quality test","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE82X0JMTVZkOUhDVWJYa0dvYnlGVnc1bkxQbERJbkRlUzF2YWx1SlBzMDVsQjFZREdGZVBYbzI4SlJtN1JfdURyaEpWdlB6bjZsNVFVRGJUMnNpUjlZelE?oc=5","date":"2022-05-02","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Laurus Labs Limited (LAURUSLABS.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Laurus Labs Limited (LAURUSLABS.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE4ta1Y1WnNPcjA3ckwyRnFqUS11ekVaczNTWXdqclRHMXNjZ3dvS0gtYUl5YUlNS2hybHdWWlQ0Slpkd2JkVVRtZV9waG1nWkZZbTd0bXlSWTBsdXRIWUE?oc=5","date":"2018-07-13","type":"pipeline","source":"Yahoo Finance UK","summary":"Abbott India Limited (ABBOTINDIA.NS) stock price, news, quote and history - Yahoo Finance UK","headline":"Abbott India Limited (ABBOTINDIA.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE02VzhHMi1lZkFVaHFadU5yLXBIcWdjNS0xdHN4MlNNR0ZtMWpzY0I0SlE3bjdoVHJhQTNQczU0VS1fa2RzMndHSzR4VkI3anpwcG5lck9fcnhXS21ENW56SkF3?oc=5","date":"2017-12-30","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Alkem Laboratories Limited (ALKEM.NS) company profile and facts - Yahoo Finance Singapore","headline":"Alkem Laboratories Limited (ALKEM.NS) company profile and facts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE0wNFJ4bTl3dlZYdnBiSklRRExCRU1xa3lFSG5DRkhGNy1JaHU0QkRsWC1YVUhGeVFFTDU4bVo1RldVWXF1cGd4MFRUWS1hLXk2TGVDTEl3N1dMa0FyVWc?oc=5","date":"2017-08-24","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Abbott India Limited (ABBOTINDIA.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Abbott India Limited (ABBOTINDIA.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE5UbFlSTVU4d0ViZVVIOE5uT2NVdWxTUVc5TVdrS19HRk9LaExTZUJ2RG1KbDQxLTZETlQydUlfR2s0SnBNM2tQckpNMGEyeEphRHo2LXJGWV8yeE1tN2c?oc=5","date":"2017-08-08","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Ajanta Pharma Limited (AJANTPHARM.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Ajanta Pharma Limited (AJANTPHARM.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE94dTB2bUlQRGp3bWlkS0dmN1VwVXI4OXpFaVdyUTNxaHc5TEtMSjFVM1R5clpPRmZHRXA0OTRFX2EyaHlwOENiUzlzdWJQR3Z6eDIyX1VydkNIdw?oc=5","date":"2017-06-07","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Ipca Laboratories Limited (IPCALAB.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Ipca Laboratories Limited (IPCALAB.NS) stock price, news, quote and history","sentiment":"neutral"}],"patents":[{"drugName":"Metformin","drugSlug":"metformin","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":50000000},{"drugName":"Ceftriaxone","drugSlug":"ceftriaxone","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":100000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Sun Pharmaceutical Industries","Cipla Limited","Dr. Reddy's Laboratories"],"therapeuticFocus":["Anti-Infectives","Gastrointestinal (GI) Generics"],"financials":{"source":"yahoo_finance","revenue":1337157528.1588001,"revenuePeriod":"2025-03-31","revenueHistory":[{"period":"2025-03-31","value":1337157528.1588001},{"period":"2024-03-31","value":1299001720.5176},{"period":"2023-03-31","value":1194689895.309},{"period":"2022-03-31","value":1097747535.7122}],"grossProfit":829894559.7218,"grossProfitHistory":[{"period":"2025-03-31","value":829894559.7218},{"period":"2024-03-31","value":773545351.2178},{"period":"2023-03-31","value":674397477.7522},{"period":"2022-03-31","value":650453241.2476}],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":168140148.4514,"operatingIncome":228094202.5402,"operatingIncomeHistory":[{"period":"2025-03-31","value":228094202.5402},{"period":"2024-03-31","value":207274444.0164},{"period":"2023-03-31","value":139324357.8758},{"period":"2022-03-31","value":184750424.7758}],"netIncome":226136182.4152,"netIncomeHistory":[{"period":"2025-03-31","value":226136182.4152},{"period":"2024-03-31","value":187528202.6598},{"period":"2023-03-31","value":102774648.8758},{"period":"2022-03-31","value":171848377.4988}],"eps":181.11,"epsHistory":[{"period":"2025-03-31","value":181.11},{"period":"2024-03-31","value":150.19},{"period":"2023-03-31","value":82.31},{"period":"2022-03-31","value":137.63}],"cash":31760652.8436,"cashHistory":[{"period":"2025-03-31","value":31760652.8436},{"period":"2024-03-31","value":47521931.6418},{"period":"2023-03-31","value":28592315.212},{"period":"2022-03-31","value":24246032.6732}],"totalAssets":1847441591.114,"totalLiabilities":549025710.2178,"totalDebt":144204266.166,"equity":1251552888.2938,"operatingCashflow":199753558.1816,"operatingCashflowHistory":[{"period":"2025-03-31","value":199753558.1816},{"period":"2024-03-31","value":203432547.4618},{"period":"2023-03-31","value":175699672.55},{"period":"2022-03-31","value":116021307.6948}],"capex":-70553469.6988,"capexHistory":[{"period":"2025-03-31","value":-70553469.6988},{"period":"2024-03-31","value":-27077068.7046},{"period":"2023-03-31","value":-24322264.9234},{"period":"2022-03-31","value":-35388472.5312}],"freeCashflow":129200088.4828,"dividendsPaid":-52696326.1588,"buybacks":null,"employees":18785,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":null,"ebit":85975358.34200001,"ebitda":95897037.9194,"period":"2025-12-31","revenue":390227667.3868,"epsBasic":53.19,"netIncome":66418131.194800004,"rdExpense":null,"epsDiluted":53.19,"grossProfit":257321438.4114,"operatingIncome":76544489.1426},{"sga":null,"ebit":97206561.779,"ebitda":106982042.5204,"period":"2025-09-30","revenue":417814343.4626,"epsBasic":63.99,"netIncome":79893486.7644,"rdExpense":null,"epsDiluted":63.99,"grossProfit":271507946.8904,"operatingIncome":86378449.4184},{"sga":null,"ebit":83624689.9146,"ebitda":92780914.1578,"period":"2025-06-30","revenue":352040531.4236,"epsBasic":55.56,"netIncome":69367170.5724,"rdExpense":null,"epsDiluted":55.56,"grossProfit":229738939.4452,"operatingIncome":68021097.0038},{"sga":null,"ebit":40758146.922,"ebitda":52505223.394600004,"period":"2025-03-31","revenue":311596711.999,"epsBasic":null,"netIncome":31940268.5564,"rdExpense":null,"epsDiluted":null,"grossProfit":168262328.9072,"operatingIncome":32167921.029600002},{"sga":null,"ebit":80106519.354,"ebitda":89012117.0212,"period":"2024-12-31","revenue":352368434.5272,"epsBasic":52.34,"netIncome":65352968.2468,"rdExpense":null,"epsDiluted":52.34,"grossProfit":226602974.41300002,"operatingIncome":70395783.8114},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":57.6,"netIncome":null,"rdExpense":null,"epsDiluted":57.6,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":5576.5,"previousClose":5462.5,"fiftyTwoWeekHigh":5933.5,"fiftyTwoWeekLow":4716.2,"fiftyTwoWeekRange":"4716.2 - 5933.5","fiftyDayAverage":5420.72,"twoHundredDayAverage":5503.59,"beta":0.29,"enterpriseValue":6577528830.304977,"forwardPE":29.3,"priceToBook":5,"priceToSales":4.68,"enterpriseToRevenue":4.42,"enterpriseToEbitda":22.21,"pegRatio":0,"ebitda":296084499.876991,"ebitdaMargin":19.9,"freeCashflow":0,"operatingCashflow":0,"totalDebt":245989981.67064986,"debtToEquity":17.1,"currentRatio":0,"returnOnAssets":0,"returnOnEquity":0,"analystRating":"","recommendationKey":"none","numberOfAnalysts":21,"targetMeanPrice":5930.33,"targetHighPrice":6913,"targetLowPrice":4360,"dividendRate":51,"payoutRatio":0.23,"fiveYearAvgDividendYield":0.83,"exDividendDate":1771545600,"insiderHeldPercent":62.9,"institutionHeldPercent":24.8,"sharesOutstanding":119565000,"floatShares":39178784,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":198.29,"epsForward":190.51,"revenuePerShare":1192.01,"bookValue":1116.26,"officers":[{"age":84,"name":"Mr. Basudeo Narian Singh","title":"Executive Chairman"},{"age":43,"name":"Mr. Sandeep Derjit Singh","title":"MD & Executive Director"},{"age":62,"name":"Mr. Mritunjay Kumar Singh","title":"Executive Director"},{"age":37,"name":"Mr. Srinivas  Singh","title":"Executive Director"},{"age":60,"name":"Ms. Madhurima  Singh","title":"Executive Director"},{"age":null,"name":"Dr. Vikas  Gupta","title":"Chief Executive Officer"},{"age":56,"name":"Dr. Akhilesh D. Sharma","title":"President & Chief Medical Officer"},{"age":54,"name":"Mr. Rajorshi  Ganguli","title":"President & Global HR Head"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"","website":"https://www.alkemlabs.com","phone":"91 22 3982 9999"}}